ALG Health Revenue and Competitors
Estimated Revenue & Valuation
- ALG Health's estimated annual revenue is currently $2.8M per year.
- ALG Health's estimated revenue per employee is $251,000
Employee Data
- ALG Health has 11 Employees.
- ALG Health grew their employee count by -8% last year.
ALG Health's People
Name | Title | Email/Phone |
---|
ALG Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $470.6M | 1592 | 4% | N/A | N/A |
#2 | $16.3M | 53 | 0% | N/A | N/A |
#3 | $7.8M | 31 | 0% | N/A | N/A |
#4 | $3.8M | 14 | 17% | N/A | N/A |
#5 | $21.1M | 68 | -1% | N/A | N/A |
#6 | $70M | 279 | 8% | N/A | N/A |
#7 | $4M | 13 | 0% | N/A | N/A |
#8 | $135.3M | 539 | 0% | N/A | N/A |
#9 | $11.5M | 42 | 11% | N/A | N/A |
#10 | $8.8M | 35 | 35% | N/A | N/A |
What Is ALG Health?
Located in northwest Ohio, we manufacture N95 masks in America with globally-sourced materials. Masks are available for purchase by medical facilities/providers, wholesale accounts, retailers and consumers.
keywords:N/AN/A
Total Funding
11
Number of Employees
$2.8M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ALG Health News
2022-04-06 - KU Leuven drug discovery unit involved in development of ...
... novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it has selected ALG-097558,...
2022-04-06 - Aligos Therapeutics Selects Drug Candidate ALG-097558, a ...
SARS-CoV-2 will remain a global health challenge, and despite the availability of effective vaccines, we still need potent and safe antiviral...
2022-03-30 - Early Outpatient Treatment for Covid-19 with Convalescent ...
... Brain Injury Outcomes Division (A.Y., K.L., N.A.M., A.L.G., N.K., ... S.E., S.N.B.), Johns Hopkins Bloomberg School of Public Health,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 11 | 450% | N/A |
#2 | $1.7M | 11 | 22% | N/A |
#3 | $3M | 12 | 9% | N/A |
#4 | $1.2M | 14 | -18% | N/A |
#5 | $3.4M | 17 | -6% | N/A |